Diplomat Pharmacy Inc (DPLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,420 | 5,771 | 2,739 | 9,485 | 8,214 |
| Receivables | 338,321 | 329,595 | 329,881 | 326,602 | 358,158 |
| Inventories | 181,401 | 179,083 | 174,507 | 210,573 | 169,863 |
| TOTAL | $542,177 | $541,456 | $517,671 | $556,256 | $549,726 |
| Non-Current Assets | |||||
| PPE Net | 28,204 | 29,564 | 31,244 | 34,525 | 40,924 |
| Intangibles | 527,367 | 681,836 | 836,597 | 850,402 | 1,175,231 |
| Other Non-Current Assets | 64,855 | 62,254 | 61,556 | 35,176 | 34,780 |
| TOTAL | $620,426 | $773,654 | $929,397 | $920,103 | $1,250,935 |
| Total Assets | $1,162,603 | $1,315,110 | $1,447,068 | $1,476,359 | $1,800,661 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 548,324 | 136,500 | 168,000 | 187,800 | 189,750 |
| Accounts payable and accrued liabilities | 391,869 | 347,508 | 305,466 | 331,348 | 345,222 |
| Accrued Expenses | 46,783 | 57,034 | 17,453 | 39,437 | 21,971 |
| Other current liabilities | N/A | N/A | 22,361 | N/A | 21,542 |
| TOTAL | $991,542 | $545,297 | $517,519 | $558,585 | $578,485 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 434,005 | 436,187 | 438,369 | 440,552 |
| Other Non-Current Liabilities | 38,570 | 32,794 | 32,249 | 6,365 | 4,345 |
| TOTAL | $40,029 | $470,352 | $471,669 | $452,690 | $457,320 |
| Total Liabilities | $1,031,571 | $1,015,649 | $989,188 | $1,011,275 | $1,035,805 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 75,974 | 75,830 | 74,714 | 74,490 | 74,475 |
| Common Shares | 641,557 | 636,331 | 634,214 | 629,411 | 629,283 |
| Retained earnings | -555,970 | -378,690 | -219,228 | -210,579 | 87,445 |
| Other shareholders' equity | -10,084 | -9,777 | -6,419 | -4,292 | -44 |
| TOTAL | $131,032 | $299,461 | $457,880 | $465,084 | $764,856 |
| Total Liabilities And Equity | $1,162,603 | $1,315,110 | $1,447,068 | $1,476,359 | $1,800,661 |